
3,4-MDMA is a synthetic psychedelic prodrug which is being evaluated clinically as an adjunct to psycotherapy. 3,4-MDMA is manufactured at Cayman Chemical in Ann Arbor, MI via a fully synthetic route. GMP material appropriate for clinical trials is under development.